Skip to content

Remifentanila influence on management control in intravenous Anesthesia.

Remifentanila influence on Hypnosis management in Total Intravenous Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-555htm
Enrollment
Unknown
Registered
2016-12-12
Start date
2016-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesiology, hypnosis, propofol, opioids, signs and symptoms.

Interventions

The aim of this study is to compare two target controlled induction modes and correlate the LDC, the required maintenance dose of propofol for intraoperative and the RDC, from the monitoring of the bi
Drug
D27.505.696.543

Sponsors

Centro Médico de Campinas
Lead Sponsor
Centro Médico de Campinas
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: They will be included in this study patients enrolled in the pre-anesthetic evaluation office of Campinas Medical Center Foundation; with surgical risk level 1 and 2 (which are lower risk); aged between 18 and 65 years.

Exclusion criteria

Exclusion criteria: illicit drugs and allergies to any medication used in this study

Design outcomes

Primary

MeasureTime frame
Earlier loss of consciousness in the group that used the opioid remifentanil, from the mean obtained by the bispectral index.

Secondary

MeasureTime frame
Total consumption of remifentanil and propofol obtained from the average ultilização between groups.;Awakening time obtained from the mean between groups.

Countries

Brazil

Contacts

Public ContactLuiz Eduardo Miziara

Centro Médico de Campinas

miziara.luizeduardo@gmail.com551937895386

Outcome results

None listed

Source: REBEC (via WHO ICTRP)